(MENAFN- America News Hour) According to Center for Disease Control and Prevention (CDC), HPV is
commonly transmitted infection in U.S. About 90% of anal and cervical cancers,
70% of vulvar and vaginal cancers and 60% of penile cancers are caused by human
papillomavirus infection.
About 14 million people are infected by HPV every year in U.S.
According to a
recently published report by Research Nester on 'Global Human Papillomavirus (HPV) Vaccine Market : Global Demand Analysis & Opportunity Outlook 2027' delivers detailed
overview of the global human papillomavirus (HPV) vaccine market in terms of market
segmentation by valence, by indication, by distribution channel and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter's five force model.
High unmet needs in the market are expected to create vast opportunities for the new entrants and existing players in the market. Various improvements in research and development have led to the development of the HPV vaccines market during the forecast period. On account of these factors, the market is anticipated to record a CAGR of around 5.3% during the forecast period i.e. 2019-2027. The market was valued at USD 2.4 Billion in 2018 and is expected to surpass USD 3.9 Billion by 2027.
Grow Your Business From Expert Advice @https://www.researchnester.com/sample-request-1753
The market is
segmented by valence into quadrivalent & non-avalent, bivalent and others
out of which, the quadrivalent & bivalent segment is anticipated to have
leading shares on account of increasing incidents of cervical cancer and launch
of new HPV vaccines.
The market is
further segmented by indication into cervical cancer, anal cancer, penile
cancer, vulvar cancer, oropharyngeal cancer, genital warts and others out of
which, the cervical cancer segment is anticipated to have leading shares on
account of increasing number of cases of this type of cancer in women and the segment
is anticipated to maintain its dominance during the forecast period.
On the basis of
distribution channel, the market is segmented by physicians, distributors,
government entities, public & private alliances and others out of which,
public & private alliances segment is anticipated to have leading shares on
account of many such alliances such as GAVI, focusing on vaccinating people in
developing countries.
North America is anticipated to have leading shares on account of increase in recommendations from various associations for immunization practices in U.S. Asia Pacific region is expected to have significant growth during the forecast period. GlaxoSmithKline Plc. has received an approval for Cervarix which is a product of China FDA and is projected to drive the growth of the market in the region. Initiatives taken by Government to reduce infectious diseases caused by HPV is likely to improve the market share of Middle East & Africa region.
Curious about this latest version of report? Obtain Report Details @ https://www.researchnester.com/reports/global-human-papillomavirus-vaccine-market/1753
Increasing Initiatives and Cancer Cases to Encourage the Market Growth
According to the
Cancer Council Australia, most of the schools in Australia have participated in
the National Papillomavirus Vaccination Program. There is an increase in the
number of people suffering from various types of cancers worldwide. These
factors are expected to drive the growth of the market.
The price of the
HPV vaccine is very high and is subject to variations. This factor remains a
concern for countries to budget necessary funds for long term. Moreover, people
may not be able to afford such high priced vaccines which may lead to severe
effects of the diseases caused by HPV. This is expected to hinder the growth of
the HPV vaccine market during the forecast period.
This report also
provides the existing competitive scenario of some of the key players of the global
human
papillomavirus (HPV) vaccine marketwhich includes company profiling of GlaxoSmithKline
Plc., Merck & Co. Inc., Sanofi, Johnson & Johnson, AstraZeneca, Serum
Institute of India Pvt. Ltd.
The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global human papillomavirus (HPV) vaccine market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Check Exclusive Discount Offers Available On this Report @ https://www.researchnester.com/grab-discount-1753
About Research Nester
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
Contact Us
AJ Daniel
Email:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 591
For More Update Follow- LinkedIn
| Twitter
| Xing
Research Nester
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.
MENAFN07112019007010068ID1099239609
-MENAFN07112019007010068ID1099239609-->
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.